Risk factors for early-onset and late-onset hepatocellular carcinoma in asian immigrants with hepatitis B in the united states

American Journal of Gastroenterology

Volumn 106, Issue 11, 2011, Pages 1994-2000

  Wan, David W ^a   Tzimas, Demetrios ^a   Smith, Joshua A ^a   Kim, Sunnie ^a   Araujo, James ^a   David, Ramoncito ^a   Lobach, Iryna ^a   Sarpel, Umut ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN;

ADULT; AGED; ARTICLE; ASIAN; CANCER RISK; CANCER SCREENING; CHRONIC HEPATITIS; CHRONIC HEPATITIS B; CLINICAL FEATURE; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; EARLY ONSET HEPATOCELLULAR CARCINOMA; FAMILY HISTORY; FEMALE; GENDER; HEPATITIS B; HUMAN; IMMIGRANT; INFORMATION PROCESSING; INTERNATIONAL NORMALIZED RATIO; LATE ONSET HEPATOCELLULAR CARCINOMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; THROMBOCYTE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PLATELET COUNT; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; SEX FACTORS; SMOKING; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 80655148993     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.302     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004; 127: S27-34. (Pubitemid 39423367)
3. Nguyen VT, Law MG, Dore GJ. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat 2009; 16: 453-63.
4. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417-22.
5. Yu E, Chie W, Chen T. Does screening or surveillance for primary hepatocellular carcinoma with ultrasonography improvethe prognosis of patients? Cancer 2005; 10: 317-25. (Pubitemid 44403470)
6. Yuen MF, Cheng CC, LauderiJ et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000; 31: 330-5.
7. Sarpel U, Schwartz M. Liver transplantation for hepatocellular carcinoma. Hepatol Res 2007; 37 (Suppl 2): S264-6.
8. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-2.
9. Lok ASF. Prevention of hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 2004; 127: S303-9.
10. Yang H-I, Lu S-N, Liaw Y-F et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-74. (Pubitemid 34764820)
11. Chen C-J, Yang H-I, Su J et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73. (Pubitemid 43042691)
12. Chen C-J, Liang K-Y, Chang A-S et al. Eff ects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991; 13: 398-406.
13. Liu C-J, Chen B-F, Chen P-J et al. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. J Infect Dis 2006; 193: 1258-65.
14. Fattovich G, Stroff olini T, Zagni I et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 1: S35-50. (Pubitemid 39423368)
15. R Development Coreteam. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria. 2008. ISBN 3-900051-07-0, URL ( http://www.R-project.org ).
16. Yu MW, Hsu FC, Sheen IS et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997; 145: 1039-47.
17. Chang PE, Ong WC, Lui HF et al. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 2008; 43: 881-8.
18. Kim JH, Choi MS, Lee H et al. Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol 2006; 21: 588-94.
19. Chen CH, Chang TT, Cheng KS et al. Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factorin the survival of hepatocellular carcinoma patients. Liverint 2006; 26: 766-73.
20. Lam CM, Chan AO, Ho P et al. Diff erent presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients-implications for screening. Aliment Pharmacol Ther 2004; 19: 771-7. (Pubitemid 38496643)
21. Wands J. Hepatocellular cancer and sex. N Engl J Med 2007; 357: 1974.
22. Beasley R. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988; 61: 1942-56.
23. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007; 37 (Suppl 2): S88-94.
24. Yu MW, Chang HC, Liaw YF et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancerinst 2000; 92: 1159-64.
25. Chuang SC, Lee YC, Hashibe M et al. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a metaanalysis. Cancer Epidemiol Biomarkers Prev 2010; 19: 1261-8.
26. Wang LY, Chen CJ, Zhang YJ et al. 4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am J Epidemiol 1998; 147: 315-23.
27. Yu MW, Pai CI, Yang SY et al. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk. Gut 2000; 47: 703-9.
28. Arguedas MR, Chen VK, Eloubeidi MA et al. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol 2003; 98: 679-90. (Pubitemid 36348544)
29. Lin OS, Keeff e EB, Sanders GD et al. Cost-eff ectiveness of screening for hepatocellular carcinoma in patients with cirrhosis dueto chronic hepatitis C. Aliment Pharmacol Ther 2004; 19: 1159-72. (Pubitemid 38746259)